Conservatorship of S.A. CA1/2

CourtCalifornia Court of Appeal
DecidedFebruary 2, 2023
DocketA164805
StatusUnpublished

This text of Conservatorship of S.A. CA1/2 (Conservatorship of S.A. CA1/2) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Conservatorship of S.A. CA1/2, (Cal. Ct. App. 2023).

Opinion

Filed 2/2/23 Conservatorship of S.A. CA1/2 NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FIRST APPELLATE DISTRICT

DIVISION TWO

Conservatorship of the Person of S.A.

CONTRA COSTA COUNTY PUBLIC GUARDIAN, Petitioner and A164805 Respondent, v. (Contra Costa County Super. Ct. No. P21-01236) S.A., Objector and Appellant.

S.A. appeals from an order of conservatorship under the Lanterman- Petris-Short Act. She contends the trial court erred in admitting psychiatric records under the business records exception to the hearsay rule that contained inadmissible multiple hearsay, opinions and conclusions. We affirm. BACKGROUND I. The Petition On August 26, 2021, the Contra Costa public guardian (public guardian) filed a petition for appointment of temporary conservator and

1 conservator of the person of S.A. (Welf. & Inst. Code, §§ 5350, 5352, 5352.1.) The petition alleged that S.A. was gravely disabled as a result of a mental disorder and unwilling to accept, or incapable of accepting, treatment voluntarily. A supporting declaration from a psychiatrist at John Muir Behavioral Health Center (John Muir) attested to S.A.’s grave disability and need for a conservatorship, with explanatory details set forth in the declaration of a treating therapist. An order appointing temporary conservator was filed the same day. S.A. had been admitted to John Muir on August 5, 2021, and was discharged on September 14, 2021. She subsequently entered a different psychiatric facility, Canyon Manor, where she remained at the time of trial. With S.A.’s concurrence, several hearing dates were continued until, at a hearing on January 11, 2022, S.A. objected to the petition and requested a “time not waived” court trial. Trial was set for January 25, then continued several more times until March 1. II. The Trial The sole witness at trial was clinical psychologist Dr. Jennifer Weinstein, who testified for the public guardian as an expert in psychology and grave disability. Weinstein interviewed S.A. at Canyon Manor on February 22, 2022, for about 40 minutes, which she testified was an adequate period of time to evaluate S.A. for grave disability. Weinstein also spoke with S.A.’s conservator, social worker and father, and reviewed records from John Muir and Canyon Manor. She testified that the medical records are the kind of records commonly relied upon in her field. Based on the interviews and her review of the medical records, Weinstein concluded that S.A. was gravely disabled.

2 Weinstein diagnosed S.A. with schizophrenia. This diagnosis requires the presence for more than a month of two or more symptoms, one of which must be disorganized speech, delusions or hallucinations (“positive symptoms”) and the other of which may be a “negative symptom” such as lack of motivation, isolating oneself or difficulty with activities of daily living. The symptoms interfere with judgment, insight, cognition, and ability to plan and follow through on a plan, take care of needs like hygiene and shelter, and interact socially with appropriateness. Weinstein testified that schizophrenia is a chronic disorder but there may be times when symptoms are more severe and times when they are “more managed.” S.A. was taking Clozaril, an antipsychotic medication that requires a blood test every two weeks to monitor for a rare blood disease. Weinstein testified that medication can help reduce symptoms, case management can help maintain self-care and use of medication, and living in a structured placement can be a treatment for a patient who needs daily intervention assistance. A. S.A.’s Interview Weinstein testified that S.A. was oriented to who and where she was during the interview on February 22. S.A. told Weinstein that prior to her placement she had tried to exit a vehicle “while being driven or about to be driven” by her case manager, and said that she would have been harmed if she had not tried to exit the vehicle. S.A. made comments that Weinstein deemed delusional, including that “in 2017 someone on drugs got into her body and made her overdose on DMT, which is a type of drug” and “ ‘[t]hey got into my body and lifted up out of my body.’ ” Weinstein testified that S.A. had “some insight” into having a mental health condition: S.A. said she had previously been diagnosed with “dissociative identity disorder amnesia and bipolar disorder” and “agree[d]

3 with those diagnoses, but [was] also diagnosed with schizoaffective disorder and [did] not agree with that diagnosis.” Weinstein explained that “insight” in this context means the patient’s understanding of her own psychiatric condition and needs for psychiatric care, which is often correlated with an ability to willingly engage in needed treatment. S.A. told Weinstein that her history of symptoms included auditory hallucinations, depression, anxiety and trouble focusing. She said she had previously taken the medication Invega Sustenna at a local clinic, and had been taking Clozaril for five months. She told Weinstein that if the conservatorship ended, she planned to live with her fiancé. She declined to give a name or number for the fiancé, saying she had had people stalk her, she did not feel comfortable sharing and she did not think he would want her to share his private information. S.A. told Weinstein that people had followed her to her fiancé’s house and said they would “light a bomb . . . [¶] [o]n fire” if she went to his house. Weinstein testified that paranoid delusions—concerns “that others are out to harm oneself” and “collaborating against oneself”—are a symptom of schizophrenia. B. Records-Based Testimony Weinstein was asked about a number of entries in S.A.’s medical records from John Muir (exhibit 2) and Canyon Manor (exhibit 3), which were admitted over S.A.’s objections, with redactions, as business records under Evidence Code section 1271.1

1Further statutory references will be to the Evidence Code unless otherwise specified. Counsel for the public guardian offered the records into evidence under section 1271, stating that they were accompanied by declarations complying with section 1561. S.A.’s attorney objected that several entries within the

4 Weinstein testified that an entry in exhibit 2 stating that “patient upon arriving to the unit continued to be very psychotic and disorganized,” and describing S.A. as “labile, agitated, aggressive towards staff and requiring physical restraint,” showed the psychiatric symptoms S.A. was suffering from when she transitioned from the community to the psychiatric facility. A description of S.A. as “appearing internally preoccupied, uncooperative and disorganized,” which are symptoms that “can significantly interfere with functionality” when unmanaged, supported the diagnosis of schizophrenia. Asked about the notation “active AH” in an August 9, 2021 entry, Weinstein testified that “AH” stands for auditory hallucinations. She testified that the entry, which read, “ ‘active AH, believes she’s possessed by Satan,’ ” was evidence of a symptom of schizophrenia that she relied upon in forming her diagnosis, and that auditory hallucinations and “delusional belief of possession” can interfere with thinking, judgment and decision-making. Weinstein testified that a note stating, “ ‘[r]eports being possessed by multiple persons’” was similar to a statement S.A. made during the February 2022 interview and revealed a delusion, which is a symptom of schizophrenia. Another note stated “ ‘DZ Zyprexa due to,’ quote, ‘it has a chemical in it that’s not good.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Palmer v. Hoffman
318 U.S. 109 (Supreme Court, 1943)
Melendez-Diaz v. Massachusetts
557 U.S. 305 (Supreme Court, 2009)
People v. Dorsey
43 Cal. App. 3d 953 (California Court of Appeal, 1974)
People v. Young
189 Cal. App. 3d 891 (California Court of Appeal, 1987)
People v. Salcido
246 Cal. App. 2d 450 (California Court of Appeal, 1966)
Jazayeri v. Mao
174 Cal. App. 4th 301 (California Court of Appeal, 2009)
Hernandez v. California Hospital Medical Center
93 Cal. Rptr. 2d 97 (California Court of Appeal, 2000)
People v. Reyes
526 P.2d 225 (California Supreme Court, 1974)
People v. Sanchez
374 P.3d 320 (California Supreme Court, 2016)
Koper v. K.W. (In re K.W.)
221 Cal. Rptr. 3d 622 (California Court of Appeals, 5th District, 2017)
Pub. Guardian of the Cnty. of San Luis Obispo v. S.A. (In re S.A.)
235 Cal. Rptr. 3d 744 (California Court of Appeals, 5th District, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Conservatorship of S.A. CA1/2, Counsel Stack Legal Research, https://law.counselstack.com/opinion/conservatorship-of-sa-ca12-calctapp-2023.